Development of Neutralizing Antibodies Against SARS-CoV-2, Using a High-Throughput Single-B-cell Cloning Method

Yang Dou,Ke Xu,Yong-Qiang Deng,Zijing Jia,Jun Lan,Xiaoyu Xu,Guorui Zhang,Tianshu Cao,Pan Liu,Xiangxi Wang,Xinquan Wang,Lingjie Xu,Pan Du,Cheng-Feng Qin,Hong Liu,Yafeng Li,Guizhen Wu,Kang Wang,Bai Lu

DOI: https://doi.org/10.1093/abt/tbad002

2023-01-01

Antibody Therapeutics

Abstract:Background:Rapid and efficient strategies are needed to discover neutralizing antibodies (nAbs) from B cells derived from virus-infected patients.Methods:Here, we report a high-throughput single-B-cell cloning method for high-throughput isolation of nAbs targeting diverse epitopes on the SARS-CoV-2-RBD (receptor binding domain) from convalescent COVID-19 patients. This method is simple, fast and highly efficient in generating SARS-CoV-2-neutralizing antibodies from COVID-19 patients' B cells.Results:Using this method, we have developed multiple nAbs against distinct SARS-CoV-2-RBD epitopes. CryoEM and crystallography revealed precisely how they bind RBD. In live virus assay, these nAbs are effective in blocking viral entry to the host cells.Conclusion:This simple and efficient method may be useful in developing human therapeutic antibodies for other diseases and next pandemic.